Anaplastic (Malignant) Meningioma — Trials

Anaplastic (Malignant) Meningioma — Trials · CancerIndex

Clinical trials

Registered studies

15 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2
Recruiting: 2
Ph III recruiting: 0
Growth YoY: —
Industry share: 50%
Top sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (5)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04541082	Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms	recruiting	Phase 1	102	Jazz PharmaceuticalsINDUSTRY	1	Dec 18, 2025	clinicaltrials
NCT05793034	Predictive Factors for Survival in Aggressive Meningiomas(23Men)	recruiting	N/A	250	Fondazione Policlinico Universitario Agostino Gemelli IRCCSOTHER	1	Mar 13, 2025	clinicaltrials